Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion
Condition(s) studied
Investigational drug(s) / intervention(s)
Endovascular Therapy: Endovascular therapy, as an adjunct to standard stroke therapy, may be beneficial for a very select population of patients who present with an acute ischemic stroke and have a proven large, proximal occlusion on imaging. Endovascular therapy includes any one or more of the following: Intra-arterial thrombolytic therapy, aspiration, stent retrieval, or a combination of multiple mechanical devices.
Study summary
Endovascular thrombectomy (EVT) for posterior circulation occlusion is generally performed within a window of less than 24 hours from the time the patient was last known well (LKW). The efficacy and safety of EVT beyond the 24-hour window remain uncertain.
Eligibility
Primary outcome measure(s)
- proportion of patients with Modified ranking scale (mRS) (0-3) at 90 days — 90(±14)days
A 0-6 scale running from perfect health without symptoms to death.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tianjin Huanhu Hospital | Tianjin | Tianjin Municipality |
More Tianjin Huanhu Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06510634 on ClinicalTrials.gov ↗ ← All trials in China